Search research articles
Contact Us
Filters
Showing results (81-90 of 128) with videos related to
Page
of 13
Sort By:
Blood
|
August 23, 2003
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines
Paul La Rosée, Kara Johnson, Amie S Corbin, et al.
Advances in Radiation Oncology
|
January 28, 2021
Reirradiation for Locoregional Recurrent Breast Cancer
Sayeh Fattahi, Safia K Ahmed, Sean S Park, et al.
Radiation Oncology (London, England)
|
November 23, 2019
3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen
Robert W Mutter, Krishan R Jethwa, Karthik Gonuguntla, et al.
Breast Cancer Research and Treatment
|
April 19, 2017
Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT)
Krishan R Jethwa, Mohamed M Kahila, Thomas J Whitaker, et al.
Journal of Cardiovascular Development and Disease
|
October 27, 2023
Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
Muhannad Aboud Abbasi, Giulia Bruno, Cristina Di Stefano, et al.
Blood
|
June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
Anupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
The Annals of Thoracic Surgery
|
May 1, 1996
Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury
S D Thies, R S Corbin, C D Goff, et al.
Blood
|
November 21, 2007
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
Jeffrey W Tyner, Denise K Walters, Stephanie G Willis, et al.
Leukemia
|
September 10, 2005
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib
L C Crossman, T O'Hare, T Lange, et al.
Leukemia
|
October 26, 2002
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
A Hochhaus, S Kreil, A S Corbin, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 128) with videos related to
Sort By:
Page
of 13
Blood
|
August 23, 2003
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines
Paul La Rosée, Kara Johnson, Amie S Corbin, et al.
Advances in Radiation Oncology
|
January 28, 2021
Reirradiation for Locoregional Recurrent Breast Cancer
Sayeh Fattahi, Safia K Ahmed, Sean S Park, et al.
Radiation Oncology (London, England)
|
November 23, 2019
3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen
Robert W Mutter, Krishan R Jethwa, Karthik Gonuguntla, et al.
Breast Cancer Research and Treatment
|
April 19, 2017
Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT)
Krishan R Jethwa, Mohamed M Kahila, Thomas J Whitaker, et al.
Journal of Cardiovascular Development and Disease
|
October 27, 2023
Detection of Early Myocardial Dysfunction by Imaging Biomarkers in Cancer Patients Undergoing Photon Beam vs. Proton Beam Radiotherapy: A Prospective Study
Muhannad Aboud Abbasi, Giulia Bruno, Cristina Di Stefano, et al.
Blood
|
June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
Anupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
The Annals of Thoracic Surgery
|
May 1, 1996
Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury
S D Thies, R S Corbin, C D Goff, et al.
Blood
|
November 21, 2007
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
Jeffrey W Tyner, Denise K Walters, Stephanie G Willis, et al.
Leukemia
|
September 10, 2005
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib
L C Crossman, T O'Hare, T Lange, et al.
Leukemia
|
October 26, 2002
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
A Hochhaus, S Kreil, A S Corbin, et al.
Page
of 13